» Articles » PMID: 37969852

Coronary Artery Calcium Scoring in Asymptomatic Patients

Overview
Specialty Health Services
Date 2023 Nov 16
PMID 37969852
Authors
Affiliations
Soon will be listed here.
Abstract

Coronary artery calcium (CAC) scoring is an important prognostic tool for personalized cardiovascular preventive care and has recently been incorporated into American College of Cardiology/American Heart Association guidelines. CAC provides direct visualization and quantification of CAC burden for risk stratification and primary prevention of cardiovascular events in an asymptomatic population. CAC scoring is recommended for individuals with intermediate 10-year atherosclerotic cardiovascular disease (ASCVD) risk and selective populations with borderline ASCVD risk. In this review, we outline the interpretation of CAC scores for predicting the risk of cardiovascular events, and we highlight the guidelines for starting statin and potentially starting aspirin therapy. A CAC score of 0 is the strongest negative predictive factor for cardiovascular disease (CVD), and a 0 score can successfully de-risk a patient. On the contrary, higher CAC scores correlate with worse cardiovascular prognostic outcomes. The CAC scan is a widely available and reproducible means for an early look at the atherosclerotic burden, and it can help strategize early interventions. The CAC interpretation and the decision to start treatment need to be personalized based on individual risk factors. We believe the emerging literature supports our contention that the CAC score can be used more broadly to improve the prophylaxis and treatment of a wider range of apparently healthy patients.

Citing Articles

Coronary Artery Calcium Is Independently Associated with Arterial Stiffness and LDL Cholesterol Burden in Patients with Familial Hypercholesterolemia.

Mattina A, Giammanco A, Noto D, Geraci G, Nardi E, Barbagallo C J Clin Med. 2025; 14(4).

PMID: 40004776 PMC: 11856069. DOI: 10.3390/jcm14041245.


Glycated Hemoglobin and Cardiovascular Disease in Patients Without Diabetes.

Jakubiak G, Chwalba A, Basek A, Cieslar G, Pawlas N J Clin Med. 2025; 14(1.

PMID: 39797136 PMC: 11721913. DOI: 10.3390/jcm14010053.


Improving cardiovascular risk prediction with machine learning: a focus on perivascular adipose tissue characteristics.

He C, Wu F, Fu L, Kong L, Lu Z, Qi Y Biomed Eng Online. 2024; 23(1):77.

PMID: 39098936 PMC: 11299393. DOI: 10.1186/s12938-024-01273-5.


Cardiac Troponin Serum Concentration Measurement Is Useful Not Only in the Diagnosis of Acute Cardiovascular Events.

Jakubiak G J Pers Med. 2024; 14(3).

PMID: 38540973 PMC: 10971222. DOI: 10.3390/jpm14030230.

References
1.
van Rosendael A, van den Hoogen I, Gianni U, Ma X, Tantawy S, Bax A . Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition. JAMA Cardiol. 2021; 6(11):1257-1266. PMC: 8374741. DOI: 10.1001/jamacardio.2021.3055. View

2.
Rumberger J, Kaufman L . A rosetta stone for coronary calcium risk stratification: agatston, volume, and mass scores in 11,490 individuals. AJR Am J Roentgenol. 2003; 181(3):743-8. DOI: 10.2214/ajr.181.3.1810743. View

3.
Sandfort V, Bluemke D . CT calcium scoring. History, current status and outlook. Diagn Interv Imaging. 2016; 98(1):3-10. DOI: 10.1016/j.diii.2016.06.007. View

4.
Xu Y, Mintz G, Tam A, McPherson J, Iniguez A, Fajadet J . Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree.... Circulation. 2012; 126(5):537-45. DOI: 10.1161/CIRCULATIONAHA.111.055004. View

5.
Kavousi M, Desai C, Ayers C, Blumenthal R, Budoff M, Mahabadi A . Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA. 2016; 316(20):2126-2134. DOI: 10.1001/jama.2016.17020. View